What are the characteristics of ventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Ventricular Tachycardia

Ventricular tachycardia is defined as three or more consecutive ventricular beats at a rate exceeding 100 bpm (cycle length <600 ms) with a wide QRS complex (≥120 ms), originating from the ventricles below the atrioventricular node. 1, 2

Core Defining Features

Rate and Duration Criteria

  • Rate >100 bpm (cycle length <600 ms), though clinically significant VT typically presents at rates >120 bpm 1, 2
  • Nonsustained VT: ≥3 beats terminating spontaneously in <30 seconds 1
  • Sustained VT: Duration >30 seconds or requiring termination due to hemodynamic compromise in <30 seconds 1

QRS Complex Characteristics

  • QRS duration ≥120 ms (0.12 seconds) in all leads—this must be verified in multiple leads as the QRS may appear deceptively narrow in 1-2 leads 3
  • QRS width >140 ms with RBBB pattern or >160 ms with LBBB pattern strongly favors VT over SVT with aberrancy 1
  • The QRS morphology differs from the patient's normal sinus QRS 4

Critical Diagnostic ECG Features

Pathognomonic Findings

  • AV dissociation with ventricular rate faster than atrial rate is diagnostic of VT (present in ~30% of cases but highly specific) 1
  • Fusion complexes (merger of conducted sinus impulses with ventricular depolarization) are pathognomonic for VT 1
  • Capture beats (occasional normally conducted sinus beats during tachycardia) confirm VT 5

Highly Suggestive ECG Criteria

The ACC/AHA/ESC guidelines provide specific morphologic criteria that strongly suggest VT 1:

  • Absence of RS complexes in all precordial leads V1-V6 (Brugada criteria) 1
  • RS interval >100 ms (onset of R wave to nadir of S wave) in any precordial lead 1
  • R-wave peak time ≥50 ms in lead II 1
  • QRS concordance (all positive or all negative) in precordial leads V1-V6—negative concordance is diagnostic for VT 1
  • Initial R wave in aVR or initial R or Q wave >40 ms in aVR (Vereckei algorithm) 1
  • Notch on descending limb of predominantly negative QRS in aVR 1
  • QR complexes indicate myocardial scar and are present in ~40% of post-MI VT 1

Morphologic Subtypes

Monomorphic VT

  • Single, stable QRS morphology throughout the tachycardia 1
  • Most commonly associated with structural heart disease, particularly prior myocardial infarction 1

Polymorphic VT

  • Continuously changing or multiform QRS morphology at cycle length 180-600 ms 1
  • Torsades de pointes: specific polymorphic VT associated with prolonged QT/QTc, characterized by twisting of QRS peaks around the isoelectric line 1

Specialized Forms

  • Ventricular flutter: Regular rhythm ~300 bpm (cycle length ~200 ms) with monomorphic appearance and no isoelectric interval between QRS complexes 1
  • Bidirectional VT: Beat-to-beat alternans in QRS frontal plane axis, classically associated with digitalis toxicity 1
  • Bundle-branch reentrant VT: Reentry involving His-Purkinje system, usually LBBB morphology, occurring with cardiomyopathy 1

Physical Examination Findings

When P waves are not visible on ECG, physical examination can reveal evidence of AV dissociation 1:

  • Irregular cannon A waves in jugular venous pulse
  • Variable intensity of first heart sound
  • Beat-to-beat variability in systolic blood pressure

Clinical Context

Hemodynamic Presentation

  • VT can present with the patient being asymptomatic to hemodynamically unstable 6
  • Pulsed VT: Patient maintains cardiac output but may have symptoms of reduced output from poor ventricular filling 6
  • Pulseless VT: No effective cardiac output—treated as cardiac arrest 1

Common Underlying Substrates

VT occurs most frequently in 1, 7, 2:

  • Chronic coronary heart disease and prior myocardial infarction
  • Cardiomyopathies (dilated, hypertrophic, arrhythmogenic right ventricular)
  • Heart failure
  • Electrolyte disturbances (hypokalemia, hypomagnesemia)
  • Medication toxicity (antiarrhythmics, digitalis)
  • Structurally normal hearts (idiopathic VT)

Critical Diagnostic Pitfalls

Common Misdiagnoses

The differential diagnosis of wide-complex tachycardia includes 1:

  • SVT with pre-existing bundle branch block
  • SVT with aberrant conduction due to tachycardia
  • SVT with conduction over accessory pathway (pre-excitation)
  • SVT with wide QRS from electrolyte/metabolic disorders
  • Paced rhythm
  • Artifact

Key Clinical Decision Rule

When wide-complex tachycardia cannot be definitively diagnosed despite careful ECG evaluation, treat as VT—this is the safest approach as most wide-complex tachycardias are ventricular in origin 1. A history of prior myocardial infarction with first occurrence of wide-complex tachycardia after the infarct strongly indicates VT 1.

Limitations of Morphologic Criteria

Width and morphologic criteria become less specific in patients taking 1:

  • Class Ia or Ic antiarrhythmic drugs
  • Those with hyperkalemia
  • Those with severe heart failure

Adenosine should be used with extreme caution when diagnosis is unclear, as it may precipitate ventricular fibrillation in patients with coronary artery disease 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Electrocardiographic manifestations: ventricular tachycardia.

The Journal of emergency medicine, 2003

Research

Differentiating wide complex tachycardias.

American family physician, 1996

Guideline

Identifying and Managing Premature Ventricular Contractions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ECG Differentiation of SVT, PSVT, and Atrial Flutter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulsed ventricular tachycardia: a case study.

British journal of nursing (Mark Allen Publishing), 2023

Research

Diagnosis and management of ventricular tachycardia.

Clinical medicine (London, England), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.